Yuan-Di Halvorsen
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 27, 2023
Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin.John J V McMurray, Scott D Solomon, J Paul Lock
|Jul 06, 2023
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trial.Yuan-Di Halvorsen, Annie L Conery, John Paul Lock
|Sep 30, 2022
A 96-week, double-blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adults.Yuan-Di Halvorsen, John Paul Lock, Juan P Frias
|Jul 13, 2019
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes.Yuan-Di C Halvorsen, Geoffrey A Walford, Joseph Massaro
Pageof 1
